<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR520.html">Part 520
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 520.2610  Trimethoprim and sulfadiazine tablets.
                            </h3>
                            <p class="depth1"><em>(a)</em> Specifications. Each tablet contains 30 milligrams (mg) (5 mg  trimethoprim and 25 mg sulfadiazine), 120 mg (20 mg trimethoprim and 100  mg sulfadiazine), 480 mg (80 mg trimethoprim and 400 mg sulfadiazine) or  960 mg (160 mg trimethoprim and 800 mg sulfadiazine).</p><p class="depth1"><em>(b)</em> Sponsors. See Nos. 000061 and 054771 in Sec. 510.600(c) of this  chapter.</p><p class="depth1"><em>(c)</em> Conditions of use in dogs--</p><p class="depth2"><em>(1)</em> Amount. Administer orally at 30  mg per kilogram of body weight (14 milligrams per pound) once daily.  Alternatively, especially in severe infections, the initial dose may be  followed by one-half the recommended daily dose every 12 hours.  Administer for 2 to 3 days after   symptoms have subsided. Do not treat for more than 14 consecutive days.</p><p class="depth2"><em>(2)</em> Indications for use. The drug is used in dogs where systemic  antibacterial action against sensitive organisms is required, either  alone or as an adjunct to surgery or debridement with associated  infection. The drug is indicated where control of bacterial infection is  required during the treatment of acute urinary tract infections, acute  bacterial complications of distemper, acute respiratory tract  infections, acute alimentary tract infections, wound infections, and  abscesses.</p><p class="depth2"><em>(3)</em> Limitations. Federal law restricts this drug to use by or on the  order of a licensed veterinarian.  [79 FR 28833, May 20, 2014]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
